Isolated split hand-split foot malformation
ORPHA:2440Malformation syndromeAutosomal dominant, Autosomal recessive, X-linked recessiveInfancy, Neonatal
Ассоциированные гены8
| Ген | Полное название | Тип связи | Тип гена | OMIM |
|---|---|---|---|---|
| DLX6 | distal-less homeobox 6 | Disease-causing germline mutation(s) in | gene with protein product | 600030 |
| EPS15L1 | epidermal growth factor receptor pathway substrate 15 like 1 | Disease-causing germline mutation(s) (loss of function) in | gene with protein product | 616826 |
| TP63 | tumor protein p63 | Disease-causing germline mutation(s) in | gene with protein product | 603273 |
| SEM1 | SEM1 26S proteasome subunit | Candidate gene tested in | gene with protein product | 601285 |
| WNT10B | Wnt family member 10B | Disease-causing germline mutation(s) in | gene with protein product | 601906 |
| DLX5 | distal-less homeobox 5 | Disease-causing germline mutation(s) in | gene with protein product | 600028 |
| BTRC | beta-transducin repeat containing E3 ubiquitin protein ligase | Candidate gene tested in | gene with protein product | 603482 |
| FBXW4 | F-box and WD repeat domain containing 4 | Role in the phenotype of | gene with protein product | 608071 |
Фенотипы (HPO)8
Очень частый (80–99%)1
HP:0012165Oligodactyly
Частый (30–79%)3
HP:0001839Split foot
HP:0004058Hand monodactyly
HP:0006101Finger syndactyly
Периодический (5–29%)4
HP:0000407Sensorineural hearing impairment
HP:0000526Aniridia
HP:0001171Split hand
HP:0004050Absent hand
Эпидемиология6
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Prevalence at birth | 1-9 / 100 000 | 5.4 | Europe | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 16.4 | China | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 5.1 | Canada | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 6 | Hungary | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 6 | United States | Value and class |
| Point prevalence | 1-9 / 100 000 | — | Europe | Class only |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)